Revolade

Medicinal product

(Invented) name

Revolade

Active substance (s)

Eltrombopagas

Strength

75 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BX05, Eltrombopag

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2010-03-11

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Eltrombopagas	75 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
57948	72070	1072070	lizdinė plokštelė	N14		Receptinis	EU/1/10/612/007	Netiekiama	-	-	No	-	-
57949	72071	1072071	lizdinė plokštelė	N28		Receptinis	EU/1/10/612/008	Netiekiama	-	-	No	-	-
57950	72072	1072072	lizdinė plokštelė	N84 (3 x 28)		Receptinis	EU/1/10/612/009	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-03-11	Registruotas